Sara Redensek
Ljubljana, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson's Disease and Dopaminergic Treatment Adverse Events.
Journal: Frontiers in aging neuroscience
Published: January 12, 2022
Serotonin-Related Functional Genetic Variants Affect the Occurrence of Psychiatric and Motor Adverse Events of Dopaminergic Treatment in Parkinson's Disease: A Retrospective Cohort Study.
Journal: Journal of personalized medicine
Published: December 18, 2021
Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies.
Journal: Frontiers in pharmacology
Published: December 13, 2021
Genetic variability in the cholecystokinin A receptor affects lipid profile and glucose tolerance in patients with polycystic ovary syndrome.
Journal: Archives of medical science : AMS
Published: October 25, 2021
Assessment of the Telomere Length and Its Effect on the Symptomatology of Parkinson's Disease.
Journal: Antioxidants (Basel, Switzerland)
Published: November 04, 2020
The role of pharmacogenomics in the personalization of Parkinson's disease treatment.
Journal: Pharmacogenomics
Published: September 07, 2020
Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson's Disease.
Journal: The international journal of neuropsychopharmacology
Published: January 28, 2020
Clinical-Pharmacogenetic Predictive Models for Time to Occurrence of Levodopa Related Motor Complications in Parkinson's Disease.
Journal: Frontiers in genetics
Published: February 17, 2019
Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease.
Journal: Journal of neuroinflammation
Published: January 15, 2019
Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease.
Journal: Frontiers in pharmacology
Published: November 06, 2018
From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.
Journal: Omics : a journal of integrative biology
Published: January 23, 2018
Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?
Journal: Frontiers in aging neuroscience
Published: October 26, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026